Camp4 Therapeutics (CAMP) director awarded 28K stock options

Rhea-AI Filing Summary

Camp4 Therapeutics Corp director and 10% owner Amir Nashat received a grant of stock options for 28,000 shares of common stock. The options have an exercise price of $4.34 per share and no cash was paid at grant. They vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of stockholders, as long as Nashat continues to provide service through that date. After this grant, he holds options for 28,000 shares, which expire on June 9, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nashat Amir

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	28,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 28,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 28,000 options Exercise price: $4.34 per share Expiration date: June 9, 2036 +2 more

5 metrics

Options granted 28,000 options Stock Option (Right to Buy) grant to Amir Nashat

Exercise price $4.34 per share Exercise price of Camp4 Therapeutics stock options

Expiration date June 9, 2036 Option expiration for Nashat’s 28,000 options

Shares underlying options 28,000 shares Common stock underlying the granted options

Total options after grant 28,000 options Total derivative holdings following this transaction

Key Terms

Stock Option (Right to Buy), exercise price, vesting, annual meeting of stockholders, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "4.3400" per share as exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The shares underlying the option vest in their entirety on the earlier of the first anniversary..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of stockholders financial

"earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders"

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nashat Amir

(Last) (First) (Middle)

C/O POLARIS PARTNERS

ONE MARINA PARK DRIVE, 8TH FL.

(Street)

BOSTON MASSACHUSETTS 02210

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Camp4 Therapeutics Corp [ CAMP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.34	06/10/2026		A		28,000		(1)	06/09/2036	Common Stock	28,000	$0	28,000	D

Explanation of Responses:

1. The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.

Remarks:

	/s/ Josh Mandel-Brehm, as Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Camp4 Therapeutics (CAMP) report for Amir Nashat?

Camp4 Therapeutics reported that director and 10% owner Amir Nashat received a grant of stock options for 28,000 shares of common stock, with an exercise price of $4.34 per share and no cash paid at grant, as compensation.

What are the key terms of Amir Nashat’s 28,000 Camp4 Therapeutics options?

The grant covers 28,000 options on Camp4 Therapeutics common stock at an exercise price of $4.34 per share. All options expire on June 9, 2036, giving a long window to exercise if vesting and service conditions are met.

When do Amir Nashat’s Camp4 Therapeutics stock options vest?

The options vest in full on the earlier of the first anniversary of the grant date or the date of Camp4 Therapeutics’ next annual meeting of stockholders, provided Nashat continues to serve the company through that vesting date.

Did Amir Nashat buy or sell Camp4 Therapeutics shares in this Form 4 filing?

This Form 4 reflects a grant of derivative securities, not an open-market trade. Nashat acquired 28,000 stock options as a grant; there were no reported purchases or sales of Camp4 Therapeutics common shares in the transaction.

How many Camp4 Therapeutics options does Amir Nashat hold after this grant?

Following the reported transaction, Amir Nashat holds options for 28,000 shares of Camp4 Therapeutics common stock. The filing shows this grant as his derivative position, with no additional remaining derivative holdings listed in the summary section.

What is the significance of the June 9, 2036 expiration for CAMP options granted to Nashat?

The options expire on June 9, 2036, giving roughly a decade-long exercise window after vesting. This long duration is typical for equity-based compensation and allows Nashat extended time to decide when to exercise, depending on service and company performance.